Contact this trialFirst, we need to learn more about you.
Serotonin-Dopamine Activity Modulator
Brilaroxazine for Schizophrenia
Recruiting1 awardPhase 3
Boston, Massachusetts
This trial is to see if the drug Brilaroxazine is effective and safe for patients with acute schizophrenia compared to a placebo, over the short and long term.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.